Primary sclerosing cholangitis - The arteriosclerosis of the bile duct?

被引:23
作者
Fickert, Peter [1 ]
Moustafa, Tarek [1 ]
Trauner, Michael [1 ]
机构
[1] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Lab Expt & Mol Hepatol, Graz, Austria
关键词
D O I
10.1186/1476-511X-6-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Primary sclerosing cholangitis ( PSC) is a chronic inflammatory disease of unknown aetiology affecting the large bile ducts and characterized by periductal fibrosis and stricture formation, which ultimately result in biliary cirrhosis and liver failure. Arteriosclerosis involves the accumulation of altered lipids and lipoproteins in large arteries; this drives inflammation and fibrosis and ultimately leads to narrowing of the arteries and hypoperfusion of dependent organs and tissues. Knowledge of the causative factors is crucial to the understanding of disease mechanisms and the development of specific treatment. Based on pathogenetic similarities between PSC and arteriosclerosis, we hypothesize that PSC represents "arteriosclerosis of the bile duct" initiated by toxic biliary lipids. This hypothesis is based on common molecular, cellular, and morphological features providing the conceptual framework for a deeper understanding of their pathogenesis. This hypothesis should stimulate translational research to facilitate the search for novel treatment strategies for both diseases.
引用
收藏
页数:8
相关论文
共 44 条
[1]   CAMs and Rho small GTPases: gatekeepers for leukocyte transendothelial migration. Focus on "VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration" [J].
Alevriadou, BR .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (02) :C250-C252
[2]   The immunobiology of primary sclerosing cholangitis [J].
Aoki, CA ;
Bowlus, CL ;
Gershwin, ME .
AUTOIMMUNITY REVIEWS, 2005, 4 (03) :137-143
[3]   Nuclear receptors in lipid metabolism: Targeting the heart of dyslipidemia [J].
Beaven, SW ;
Tontonoz, P .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :313-329
[4]   A role for oxidized phospholipids in artherosclerosis [J].
Berliner, JA ;
Watson, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (01) :9-11
[5]   Thrombospondin 1 acts as a strong promoter of transforming growth factor β effects via two distinct mechanisms in hepatic stellate cells [J].
Breitkopf, K ;
Sawitza, I ;
Westhoff, JH ;
Wickert, L ;
Dooley, S ;
Gressner, AM .
GUT, 2005, 54 (05) :673-681
[6]   EXPRESSION AND DISTRIBUTION OF OSTEOPONTIN IN HUMAN TISSUES - WIDESPREAD ASSOCIATION WITH LUMINAL EPITHELIAL SURFACES [J].
BROWN, LF ;
BERSE, B ;
VANDEWATER, L ;
PAPADOPOULOSSERGIOU, A ;
PERRUZZI, CA ;
MANSEAU, EJ ;
DVORAK, HF ;
SENGER, DR .
MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (10) :1169-1180
[7]   Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice [J].
Bruemmer, D ;
Collins, AR ;
Noh, G ;
Wang, W ;
Territo, M ;
Arias-Magallona, S ;
Fishbein, MC ;
Blaschke, F ;
Kintscher, U ;
Graf, K ;
Law, RE ;
Hsueh, WA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (09) :1318-1331
[8]   Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis [J].
Cruickshank, SM ;
Southgate, J ;
Wyatt, JI ;
Selby, PJ ;
Trejdosiewicz, LK .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (10) :730-734
[9]   The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation [J].
Cuff, CA ;
Kothapalli, D ;
Azonobi, I ;
Chun, S ;
Zhang, YM ;
Belkin, R ;
Yeh, C ;
Secreto, A ;
Assoian, RK ;
Rader, DJ ;
Puré, E .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (07) :1031-1040
[10]   2000 George Lyman Duff Memorial Lecture - Atherosclerosis is a liver disease of the heart [J].
Davis, RA ;
Hui, TY .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (06) :887-898